Branded Generics Market Projected to reach US$ 414.99 billion in 2028| Detail Report by The Insight Partners

Branded generics are generic drugs that have been given a proprietary market name. They may be marketed in a similar way as branded drugs. Branded generic drugs attach proprietary names to generic drug molecules. Some branded generics are specially made as novel dosage forms of off-patent drugs, filling in a dosage gap while offering consumers a name that is likely easier to remember than the true generic name. Branded generics are a small but profitable segment of the pharmaceutical market. Branded generics go through the same FDA approval process as other generics after branded drug patents expire.

Download PDF Copy- https://www.theinsightpartners.com/sample/TIPRE00005554/?utm_source=OpenPR&utm_medium=10637

According to our latest market study on " Branded Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)" the branded generics market is expected to grow from US$ 235.86 billion in 2022 to US$ 414.99 billion by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.The report highlights key factors driving the Branded Generics market and prominent players and their progress in the market.

The "Global Branded Generics Market Analysis to 2028" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global Branded Generics market trend analysis. The report aims to provide an overview of the market with detailed market segmentation. The market is segmented based on Therapeutic Application, Distribution Channel, Drug Class, and Formulation Type and geography. Based on therapeutic application, the global branded generics market has been segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory. Based on distribution channel, the branded generics market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. Based on drug class, the branded generics market is categorized into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptic. Based on formulation type, the branded generics market is segmented into oral, parenteral, topical, and others. Based on geography, the market is segmented into five main regions North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Asia Pacific is expected to be the fastest-growing region worldwide, followed by the Middle East & Africa.

Speak To Analyst @ https://www.theinsightpartners.com/speak-to-analyst/TIPRE00005554?utm_source=OpenPR&utm_medium=10637

Market Insights

According to a report released by VOXEU, with healthcare budgets worldwide under pressure, switching to branded generics seems a natural cost saver. Branded generics are cheaper alternatives to branded medicines, offering efficiency gains to any healthcare system. For instance, in 2016, US$ 253 billion was generated by generic medicines accounting for one-quarter of a healthcare industry.

Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Bausch Health Companies Inc., Lupin, Sanofi, AstraZeneca Plc., Dr.Reddy's Laboratories, Par Pharmaceuticals, Inc., Sandoz International GmbH, Aspen Holdings, and Hetero are among the key players operating in the Branded Generics market. The leading players adopt several strategies such as mergers & acquisitions and product launches to expand their geographic presence and consumer base.

Purchase a Copy of the Report @ https://www.theinsightpartners.com/buy/TIPRE00005554/?utm_source=OpenPR&utm_medium=10637

Report Spotlights

Progressive trends in the Branded Generics industry to help players develop effective long-term strategies
Business growth strategies adopted by companies to secure growth in developed and developing markets
Quantitative analysis of the global Branded Generics market from 2019 to 2028
Estimation of the demand for Branded Generics across various industries
PEST analysis to illustrate the efficacy of buyers and suppliers operating in the industry to predict the market growth
Recent developments to understand the competitive market scenario and the demand for Branded Generics
Market trends and outlook, coupled with factors driving and restraining the growth of the Branded Generics market
Understanding the strategies that underpin commercial interest with regard to the global Branded Generics market growth, aiding in the decision-making process
The Branded Generics market size at various nodes of market
Detailed overview and segmentation of the global Branded Generics market and its industry dynamics
The Branded Generics market size in various regions with promising growth opportunities

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our wide range of research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Food and Beverages Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.